These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The status of blood coagulation preparations within the scope of modern hemotherapy in surgical patients]. Kretschmer V. Beitr Infusionsther; 1989; 24():134-50. PubMed ID: 2481530 [Abstract] [Full Text] [Related]
3. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Levi M, Toh CH, Thachil J, Watson HG. Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477 [Abstract] [Full Text] [Related]
7. Elective fresh frozen plasma in the critically ill: what is the evidence? Verghese SG. Crit Care Resusc; 2008 Sep; 10(3):264-8. PubMed ID: 18798728 [Abstract] [Full Text] [Related]
8. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass. Avidan MS, Levy JH, van Aken H, Feneck RO, Latimer RD, Ott E, Martin E, Birnbaum DE, Bonfiglio LJ, Kajdasz DK, Despotis GJ. J Thorac Cardiovasc Surg; 2005 Jul; 130(1):107-13. PubMed ID: 15999048 [Abstract] [Full Text] [Related]
9. [Controlled substitution with blood products in hemostatic disorders]. Bucher U, Leupin L. Folia Haematol Int Mag Klin Morphol Blutforsch; 1982 Jul; 109(6):912-20. PubMed ID: 6187645 [Abstract] [Full Text] [Related]
10. Protocol and preliminary results of a clinical study for comparison of solvent/detergent-inactivated plasma VIP versus FFP with special consideration of the balance of hemostasis. Beck KH, Mortelmans Y, Kretschmer V. Beitr Infusionsther Transfusionsmed; 1994 Jul; 32():440-4. PubMed ID: 9422123 [Abstract] [Full Text] [Related]
13. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation]. Menges T, von Lessen A, Welters I, Wagner RM, Ruwoldt R, Boldt J, Hempelmann G. Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289 [Abstract] [Full Text] [Related]
15. In vitro effect of fresh frozen plasma on the activated coagulation time in patients undergoing cardiopulmonary bypass. Barnette RE, Shupak RC, Pontius J, Rao AK. Anesth Analg; 1988 Jan; 67(1):57-60. PubMed ID: 3257361 [Abstract] [Full Text] [Related]
16. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen. Osselaer JC, Debry C, Goffaux M, Pineau J, Calomme G, Dubuc E, Chatelain B, Vandendaele MC, Hsu J, Rheinschmidt M, Lin L. Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283 [Abstract] [Full Text] [Related]
17. Rational perioperative use of clotting factor concentrates and fresh frozen plasma (FFP). Muntean W. Acta Anaesthesiol Scand Suppl; 1997 Jan; 111():263-4. PubMed ID: 9421038 [No Abstract] [Full Text] [Related]
18. [Disorders of blood coagulation in the intensive care unit: what is important for diagnosis and therapy?]. Seitz R, Egbring R. Klin Wochenschr; 1991 Jan; 69 Suppl 26():143-9. PubMed ID: 1813711 [Abstract] [Full Text] [Related]
19. Supportive transfusion therapy in cancer patients with acquired defects of hemostasis. Federici AB, Intini D, Lattuada A, Vanelli C, Arrigoni L, Sacchi E, Russo U. Thromb Res; 2014 May; 133 Suppl 2():S56-62. PubMed ID: 24862147 [Abstract] [Full Text] [Related]
20. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases]. Rodríguez Gómez M, López Fernández MF, Batlle J. Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380 [Abstract] [Full Text] [Related] Page: [Next] [New Search]